Autopsy report · NCT01493375
Surgical Field Bacterial Contamination in Primary Total Hip (THA) and Knee (TKA) Arthroplasty
Cause of deathStaffing, sites or logistics
“Study principal investigator left the organization”
Life of this trial
- Registered 1 year 6 months after it had already started.
- Suspended: paused, and may or may not restart.
- 60 participants enrolled.
Vital statistics
- Status
- Suspended
- Sponsor
- Northern Orthopaedic Division, Denmark
- Sponsor type
- University, hospital or other
- Conditions
- Prosthetic Infections
- Participants
- 60
- Sites
- 1
- Countries
- Denmark
Trials that died the same way
- Ph 2 Study of TAS-102 / Bevacizumab Maintenance Therapy Post Induction Chemotherapy in Metastatic Colorectal Cancer
“Principal investigator left the institution” - Brain Function in Depression and Insulin Resistance
“Principal Investigator Left University” - Detailed Clinical, Biochemical and Genetic Characterization in Gonadotropin-releasing Hormone (GnRH) Deficiency Disorders
“the Principal Investigator left the institution” - Pilot Study of the Effect of Topical Bromfenac Ophthalmic Solution 0.09%in Patients With Acute Post-operative Cystoid Macular Edema.
“Principal Investigator left institution” - Identification and Characterization of Molecular Markers in Musculoskeletal Tumors
“Principal Investigator has left the Institution”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.